Beasley Allen in Pharmaceutical News

Articles 271 to 280 of 323 in the Pharmaceutical section.

Beasley Allen Attorney Andy Birchfield to appear on 60 Minutes November 14

Andy Birchfield, a Shareholder with the Montgomery law firm Beasley, Allen, Crow, Methvin, Portis and Miles, P.C. will appear on 60 minutes on Sunday, November 14th.

Merck Vioxx Lawsuit Leaders Chosen at New Orleans Restaurant

Attorneys representing 39 U.S. law firms met at a New Orleans restaurant and chose two lawyers to lead federal lawsuits against Merck & Co. on behalf of people claiming injuries because of the company’s Vioxx painkiller.

Merck Defends Vioxx Record

Merck & Co. Chief Executive Officer Raymond Gilmartin said Monday his first indication that the painkiller Vioxx carried a heart risk came on Sept. 23, and the company withdrew the medicine a week later.

Officials Explain Internal Documents Related to Vioxx

Merck has begun "offering explanations" for internal documents that allegedly indicated the company was aware of the safety risks of the CQX-2 inhibitor Vioxx years before the voluntary withdrawal of the medication in late September, the Wall Street Journal reports (Martinez, Wall Street J…

Beasley Allen Lawyer Birchfield Comments on Gilmartin Interview

Attorney Andy Birchfield Jr. is directing litigation against Merck &Co. by people who alleged that the painkiller caused heart attacks or strokes.

First Vioxx Fight: Where to Litigate

Attorneys involved in Vioxx litigation predict that all federal cases will be consolidated and transferred to a single venue soon after the Judicial Panel on Multidistrict Litigation meets in January.

Merck's Gilmartin Rejects Claims Vioxx Risk Ignored

Merck & Co. Chief Executive Officer Raymond Gilmartin said his first indication

Andy Birchfield Comments on Gilmartin Interview

Attorney Andy Birchfield Jr. is directing litigation against Merck & Co. by people who alleged that the painkiller caused heart attacks or strokes.

Merck's Gilmartin rejects claims Vioxx Risk Ignored

Merck & Co. Chief Executive Officer Raymond Gilmartin said his first indication that the painkiller Vioxx carried a heart risk came on Sept. 23, 2004 and the company withdrew the medicine a week later.

First Vioxx fight where to Litigate

Attorneys involved in Vioxx litigation predict that all federal cases will be consolidated and transferred to a single venue soon after the Judicial Panel on Multi-district Litigation meet.